Amazing how Alto raised $7m in a day in this market. This IPO hasn't been promoted and will will surprise many!
Anti aging drug development is a booming business in the US.
Regenerative medicine seeks to address this challenge and extend the duration of our wellness and capacity.
Dr Dixon, the founder was also the co-founder of Cynata Therapeutics (ASX:CYP) and a director of Noxopharm (ASX:NOX).
"Many scientists now believe Exosomes are the next evolution in Stem Cell technology,"
Dr. Ronald Klatz, President of the American Academy of Anti-Aging and Regenerative Medicine
Amazing how Alto raised $7m in a day in this market. This IPO...
Add EX1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.933M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EX1 (ASX) Chart |
Day chart unavailable